AMH and polycystic ovary syndrome: In addition, other clinical manifestations include a higher baseline luteinizing hormone/follicle-stimulating hormone ratio (bLH/FSH) (4, 5), higher levels of anti–Müllerian hormone (AMH) (5, 6), insulin resistance (7), and obesity, all of which are common among PCOS patients despite not being included in the diagnosis criteria for PCOS.